Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2

Oncology Reports

Volumn 25, Issue 2, 2011, Pages 503-511

  Zhou, Baocheng ^a,b   Zhou, Hong ^a   Ling, Shucai ^c   Guo, Donglin ^a   Yan, Yihong ^a   Zhou, Fang ^a   Wu, Ying ^a  

^a JIANGSU UNIVERSITY   (China)

^b Maternal and Child Care Service Centre of Lianyungang   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colonic cancer cells; Extracellular regulated protein kinase 1 2; Protease activated receptor 2; Toll like receptor 4

Indexed keywords

CASPASE 7; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEINASE ACTIVATED RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASE 3; OLIGOPEPTIDES; PHOSPHORYLATION; RECEPTOR CROSS-TALK; RECEPTOR, PAR-2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 78651367732     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1077     Document Type: Article

References (36)

1. Ossovskay VS and Bunnett NW: Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621, 2004.
2. Kirkland JG, Cottrell GS, Bunnett NW and Corvera CU: Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder. Am J Physiol Gastrointest Liver Physiol 293: G335-G346, 2007.
3. Bushell T: The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders. J Physiol 581: 7-16, 2007.
4. Ramachandran R and Hollenberg MD: Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153: S263-S282, 2007. (Pubitemid 351340983)
5. Soreide K, Janssen EA, Körner H and Baak JP: Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis. J Pathol 209: 147-156, 2006. (Pubitemid 43805409)
6. Morris DR, Ding Y, Ricks TK, et al: Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 66: 307-314, 2006. (Pubitemid 43166037)
7. Cocks TM and Moffatt JD: Protease-activated receptor-2 (PAR2) in the airways. Pulm Pharmacol Ther 14: 183-191, 2001.
8. Akashi-Takamura S and Miyake K: Toll-like receptors (TLRs) and immune disorders. J Infect Chemother 12: 233-240, 2006. (Pubitemid 44760501)
9. Lu YC, Yeh WC and Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151, 2008.
10. Nihon-yanagi Y, Park Y, Ooshiro M, Terai K, Matsumoto T, Murano T and Okazumi S: Expression of toll-like receptor 4 in colorectal cancer. Gan To Kagaku Ryoho 35: 2247-2249, 2008.
11. Zhang YB, He FL, Fang M, et al: Increased expression of Toll-like receptors 4 and 9 in human lung cancer. Mol Biol Rep 36: 1475-1481, 2009.
12. Huang B, Zhao J, Li H, et al: Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65: 5009-5014, 2005. (Pubitemid 40827306)
13. Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2002.
14. Roberts PJ and Der CJ: Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310, 2007. (Pubitemid 46763022)
15. Le Quément C, Guénon I, Gillon JY, et al: MMP-12 induces IL-8/CXCL8 secretion through EGFR and ERK1/2 activation in epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L1076-L1084, 2008.
16. Zhang W and Liu HY: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12: 9-18, 2002.
17. Liu Y and Mueller BM: Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Biophys Res Commun 344: 1263-1270, 2006.
18. Guha M, O'Connell MA, Pawlinski R, et al: Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98: 1429-1439, 2001.
19. Yao C, Lin Y, Chua MS, et al: Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. Int J Cancer 121: 1949-1957, 2007.
20. Khorana AA, Ahrendt SA, Ryan CK, et al: Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 13: 2870-2875, 2007. (Pubitemid 46849560)
21. Lakhani SA, Masud A, Kuida K, et al: Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311: 847-851, 2006. (Pubitemid 43228848)
22. Ledgerwood EC and Morison IM: Targeting the apoptosome for cancer therapy. Clin Cancer Res 15: 420-424, 2009.
23. Zhou H, Hu H, Shi W, Ling S, Wang T and Wang H: The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells. Oncol Rep 20: 1069-1076, 2008.
24. Sánchez-Hernández PE, Ramirez-Dueñas MG, Albarran-Somoza B, et al: Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation. Gynecol Oncol 108: 19-26, 2008.
25. Caruso R, Pallone F, Fina D, et al: Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. Am J Pathol 169: 268-278, 2006.
26. Zhou H, Shi W, Zhou B, Guo D and Wang T: Tissue factorfactor VIIa regulates interleukin-8, tissue factor and caspase-7 expression in SW620 cells through protease-activated receptor-2 activation. Mol Med Rep 3: 269-274, 2010.
27. Kanczkowski W, Morawietz H, Ziegler CG, et al: Pam3CSK4 and LTA-TLRs ligands associated with microdomains induce IL-8 production in human adrenocortical cancer cells. Horm Metab Res 39: 457-460, 2007. (Pubitemid 46999854)
28. He W, Liu Q, Wang L, et al: TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44: 2850-2859, 2007. (Pubitemid 46412506)
29. Wolska A, Lech-Maranda E and Robak T: Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett 14: 248-272, 2009.
30. Resman N, Gradisar H, Vasl J, et al: Taxanes inhibit human TLR4 signaling by binding to MD-2. FEBS Lett 582: 3929-3934, 2008.
31. Blüthgen N and Legewie S: Systems analysis of MAPK signal transduction. Essays Biochem 45: 95-107, 2008.
32. Balmanno K and Cook SJ: Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 16: 368-377, 2009.
33. Araki K, Shimura T, Yajima T, et al: Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8. J Biol Chem 284: 32305-32311, 2009.
34. Chen Y, Wang J, Yao Y, et al: CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway. FEBS Lett 583: 2811-2818, 2009.
35. Sivaprasad U and Basu A: Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J Cell Mol Med 12: 1265-1271, 2008.
36. Rallabhandi P, Nhu QM, Toshchakov VY, et al: Analysis of proteinase-activated receptor 2 and TLR4 signal transduction. J Biol Chem 283: 24314-24325, 2008.